诺瓦瓦克斯 NVAX
$10.78 +$1.00 (+10.22%)
休市 · Nov 6, 9:50 pm ET · 最新盘后价 $10.70 -0.74%
开盘$10.06
昨收$9.78
当日区间$10.00 – $10.93
成交量6.29M
市值$1.78B
市盈率（TTM）–
股息率–
NVAX 相关新闻
匹配 Novavax 或代码 NVAX 的头条新闻，按最新排序。
- Analysts Offer Insights on Healthcare Companies: Helus Pharma (HELP), Ultragenyx Pharmaceutical (RARE) and Novavax (NVAX)
- Cantor Fitzgerald Maintains Novavax(NVAX.US) With Buy Rating, Maintains Target Price $18
- Cantor Fitzgerald Sticks to Its Buy Rating for Novavax (NVAX)
- Novavax | SCHEDULE 13G: Others
- BofA Securities Maintains Novavax(NVAX.US) With Sell Rating, Cuts Target Price to $7 负面
- Novavax | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
- Earnings Flash (NVAX) Novavax Posts Q2 Net Loss of $0.32 a Share, Vs. FactSet Est. of $0.38 Loss 负面
- TD Cowen Maintains Novavax(NVAX.US) With Hold Rating, Maintains Target Price $9
- BofA Securities Maintains Novavax(NVAX.US) With Sell Rating, Maintains Target Price $8
- Novavax | 4: Statement of changes in beneficial ownership of securities-Director Shiver John W.
- Novavax | 4: Statement of changes in beneficial ownership of securities-Director King Rachel K.
- Novavax | 4: Statement of changes in beneficial ownership of securities-Director Newton Charles W.
- BTIG Maintains Novavax(NVAX.US) With Buy Rating, Maintains Target Price $19
- TD Cowen Initiates Novavax(NVAX.US) With Hold Rating, Announces Target Price $9
- TD Cowen Maintains Novavax(NVAX.US) With Hold Rating, Raises Target Price to $9 正面
暂无评论——快来第一个聊聊 NVAX。